{
  "id": [
    "32557557"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32557557"
  ],
  "pmcid": [
    "PMC7323156"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7323156"
      ]
    }
  ],
  "doi": [
    "10.1111/bph.15164"
  ],
  "title": [
    "Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?"
  ],
  "authorString": [
    "Sousa LP, Pinho V, Teixeira MM."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Sousa LP"
          ],
          "firstName": [
            "Lirlândia P"
          ],
          "lastName": [
            "Sousa"
          ],
          "initials": [
            "LP"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.",
                "Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Pinho V"
          ],
          "firstName": [
            "Vanessa"
          ],
          "lastName": [
            "Pinho"
          ],
          "initials": [
            "V"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.",
                "Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Teixeira MM"
          ],
          "firstName": [
            "Mauro M"
          ],
          "lastName": [
            "Teixeira"
          ],
          "initials": [
            "MM"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil."
              ]
            }
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "journalIssueId": [
        "2961924"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "British journal of pharmacology"
          ],
          "ISOAbbreviation": [
            "Br J Pharmacol"
          ],
          "medlineAbbreviation": [
            "Br J Pharmacol"
          ],
          "NLMid": [
            "7502536"
          ],
          "ISSN": [
            "0007-1188"
          ],
          "ESSN": [
            "1476-5381"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "Inflammation is generally accepted as a component of the host defence system and a protective response in the context of infectious diseases. However, altered inflammatory responses can contribute to disease in infected individuals. Many endogenous mediators that drive the resolution of inflammation are now known. Overall, mediators of resolution tend to decrease inflammatory responses and provide normal or greater ability of the host to deal with infection. In the lung, it seems that pro-resolution molecules, or strategies that promote their increase, tend to suppress inflammation and lung injury and facilitate control of bacterial or viral burden. Here, we argue that the demonstrated anti-inflammatory, pro-resolving, anti-thrombogenic and anti-microbial effects of such endogenous mediators of resolution may be useful in the treatment of the late stages of the disease in patients with COVID-19."
  ],
  "affiliation": [
    "Laboratorio de Imunofamacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil."
  ],
  "publicationStatus": [
    "aheadofprint"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "465425/2014-3"
          ],
          "agency": [
            "National Institute of Science and Technology"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1111/bph.15164"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7323156"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7323156?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2020-06-20"
  ],
  "firstIndexDate": [
    "2020-06-20"
  ],
  "fullTextReceivedDate": [
    "2020-08-20"
  ],
  "dateOfRevision": [
    "2020-09-09"
  ],
  "electronicPublicationDate": [
    "2020-06-18"
  ],
  "firstPublicationDate": [
    "2020-06-18"
  ]
}